Modulation of septin and molecular motor recruitment in the microtubule environment of the Taxol-resistant human breast cancer cell line MDA-MB-231

Proteomics

Volumn 11, Issue 19, 2011, Pages 3877-3886

  Froidevaux Klipfel, Laurence ^a   Poirier, Florence ^a   Boursier, Céline ^a   Crépin, Ronan ^a   Poüs, Christian ^a,b   Baudin, Bruno ^a,c   Baillet, Anita ^a  

^a UNIVERSITÉ PARIS SACLAY   (France)

^b HÔPITAL ANTOINE BÉCLÈRE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

Author keywords

Cell biology; Dynein; Kinesin; Microtubule; Septin; Taxol resistance

Indexed keywords

ALPHA TUBULIN; BETA TUBULIN; KINESIN 1; MICROTUBULE PROTEIN; PACLITAXEL; SEPTIN; VERAPAMIL;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CELL MDA MB 231; CANCER RESISTANCE; CELL LINE; CYTOKINESIS; CYTOSKELETON; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMAGE ANALYSIS; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MICROTUBULE; MOLECULAR DYNAMICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN TRANSPORT; PROTEOMICS; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; BREAST NEOPLASMS; CELL LINE, TUMOR; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; MICROTUBULES; PACLITAXEL; PROTEOME; PROTEOMICS; SEPTINS; TUBULIN; TUBULIN MODULATORS; UP-REGULATION;

EID: 80053013820     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.201000789     Document Type: Article

References (66)

1. O'Driscoll, L., Clynes, M., Biomarkers and multiple drug resistance in breast cancer. Curr. Cancer Drug Targets 2006, 6, 365-384.
2. Tubiana-Hulin, M., How to maximize the efficacy of taxanes in breast cancer. Cancer Treat. Rev. 2005, 31, S3-9.
3. Ring, A. E., Ellis, P. A., Taxanes in the treatment of early breast cancer. Cancer Treat. Rev. 2005, 31, 618-627.
4. Bergstralh, D. T., Ting, J. P., Microtubule stabilizing agents: their molecular signaling consequences and the potential for enhancement by drug combination. Cancer Treat. Rev. 2006, 32, 166-179.
5. McGrogan, B. T., Gilmartin, B., Carney, D. N., McCann, A., Taxanes, microtubules and chemoresistant breast cancer. Biochim. Biophys. Acta 2008, 1785, 96-132.
6. Jordan, M. A., Wendell, K., Gardiner, S., Derry, W. B. et al., Mitotic block induced in HeLa cells by low concentrations of paclitaxel (taxol) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 1996, 56, 816-825.
7. Orr, G. A., Verdier-Pinard, P., McDaid, H., Horwitz, S. B., Mechanisms of taxol resistance related to microtubules. Oncogene 2003, 22, 7280-7295.
8. Berrieman, H. K., Lind, M. J., Cawkwell, L., Do beta-tubulin mutations have a role in resistance to chemotherapy? Lancet Oncol. 2004, 5, 158-164.
9. Kavallaris, M., Kuo, D. Y., Burkhart, C. A., Regl, D. L. et al., Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 1997, 100, 1282-1293.
10. Hari, M., Yang, H., Zeng, C., Canizales, M., Cabral, F., Expression of class III beta-tubulin reduces microtubule assembly and confers resistance to paclitaxel. Cell Motil. Cytoskeleton 2003, 56, 45-56.
11. Kamath, K., Wilson, L., Cabral, F., Jordan, M. A., BetaIII-tubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J. Biol. Chem. 2005, 280, 12902-12907.
12. Derry, W. B., Wilson, L., Khan, I. A., Luduena, R. F., Jordan, M. A., Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes. Biochemistry 1997, 36, 3554-3562.
13. Goncalves, A., Braguer, D., Kamath, K., Martello, L. et al., Resistance to Taxol in lung cancer cells associated with increased microtubule dynamics. Proc. Natl. Acad. Sci. USA 2001, 98, 11737-11742.
14. Alli, E., Bash-Babula, J., Yang, J. M., Hait, W. N., Effect of stathmin on the sensitivity to antimicrotubule drugs in human breast cancer. Cancer Res. 2002, 62, 6864-6869.
15. Zhang, C. C., Yang, J. M., White, E., Murphy, M. et al., The role of MAP4 expression in the sensitivity to paclitaxel and resistance to vinca alkaloids in p53 mutant cells. Oncogene 1998, 16, 1617-1624.
16. Sudo, T., Nitta, M., Saya, H., Ueno, N. T., Dependence of paclitaxel sensitivity on a functional spindle assembly checkpoint. Cancer Res. 2004, 64, 2502-2508.
17. Lu, J., Tan, M., Huang, W. C., Li, P. et al., Mitotic deregulation by survivin in ErbB2-overexpressing breast cancer cells contributes to taxol resistance. Clin. Cancer Res. 2009, 15, 1326-1334.
18. Small, G. W., Shi, Y. Y., Higgins, L. S., Orlowski, R. Z., Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance. Cancer Res. 2007, 67, 4459-4466.
19. Roy, S. N., Horwitz, S. B., A phosphoglycoprotein associated with taxol resistance in J774. 2 cells. Cancer Res. 1985, 45, 3856-3863.
20. Phung-Koskas, T., Pilon, A., Poüs, C., Betzina, C. et al., STAT5B-mediated growth hormone signaling is organized by highly dynamic microtubules in hepatic cells. J. Biol. Chem. 2005, 280, 1123-1131.
21. Crossett, B., Edwards, A. V., White, M. Y., Cordwell, S. J., Statistical analysis of image data provided by two-dimensional gel electrophoresis for discovery proteomics. Methods Mol. Med. 2008, 141, 271-285.
22. Lescuyer, P., Strub, J. M., Luche, S., Diemer, H. et al., Progress in the definition of a reference human mitochondrial proteome. Proteomics 2003, 3, 157-167.
23. Liebmann, J. E., Cook, J. A., Lipschultz, C., Teague, D. et al., Cytotoxic studies of paclitaxel (taxol) in human tumour cell lines. Br. J. Cancer 1993, 68, 1104-1109.
24. Hari, M., Loganzo, F., Annable, T., Tan, X. et al., Paclitaxel-resistant cells have a mutation in the paclitaxel-binding region of beta-tubulin (Asp26Glu) and less stable microtubules. Mol. Cancer Ther. 2006, 5, 270-278.
25. Geeraert, C., Ratier, A., Pfisterer, S. G., Perdiz, D. et al., Starvation-induced hyperacetylation of tubulin is required for the stimulation of autophagy by nutrient deprivation. J. Biol. Chem. 2010, 285, 24184-24194.
26. Kinoshita, M., Assembly of mammalian septins. J. Biochem. 2003, 134, 491-496.
27. Cao, L., Ding, X., Yu, W., Yang, X. et al., Phylogenetic and evolutionary analysis of the septin protein family in metazoan. FEBS Lett. 2007, 581, 5526-5532.
28. Longtine, M. S., DeMarini, D. J., Valencik, M. L., Al-Awar, O. S. et al., The septins: roles in cytokinesis and other processes. Curr. Opin. Cell Biol. 1996, 8, 106-119.
29. Spiliotis, E. T., Nelson, W. J., Here come the septins: novel polymers that coordinate intracellular functions and organization. J. Cell Sci. 2006, 119, 4-10.
30. Gonzalez, M. E., Peterson, E. A., Privette, L. M., Loffreda-Wren, J. L. et al., High SEPT9-v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res. 2007, 67, 8554-8564.
31. Kinoshita, M., The septins. Genome Biol. 2003, 4, 236.
32. Gache, V., Waridel, P., Winter, C., Juhem, A. et al., Xenopus meiotic microtubule-associated interactome. PLoS One 2010, 5, e9248.
33. Patel, P. C., Fisher, K. H., Yang, E. C., Deane, C. M., Harrison, R. E., Proteomic analysis of microtubule-associated proteins during macrophage activation. Mol. Cell. Proteomics 2009, 8, 2500-2514.
34. Petrak, J., Ivanek, R., Toman, O., Cmejla, R. et al., Deja vu in proteomics. A hit parade of repeatedly identified differentially expressed proteins. Proteomics 2008, 8, 1744-1749.
35. Redmond, T., Sanchez, E. R., Bresnick, E. H., Schlesinger, M. J. et al., Immunofluorescence colocalization of the 90-kDa heat-shock protein and microtubules in interphase and mitotic mammalian cells. Eur. J. Cell Biol. 1989, 50, 66-75.
36. Garnier, C., Barbier, P., Gilli, R., Lopez, C. et al., Heat-shock protein 90 (hsp90) binds in vitro to tubulin dimer and inhibits microtubule formation. Biochem. Biophys. Res. Commun. 1998, 250, 414-419.
37. Giustiniani, J., Daire, V., Cantaloube, I., Durand, G. et al., Tubulin acetylation favors Hsp90 recruitment to microtubules and stimulates the signaling function of the Hsp90 clients Akt/PKB and p53. Cell Signal. 2009, 21, 529-539.
38. Chuthapisith, S., Layfield, R., Kerr, I. D., Hughes, C., Eremin, O., Proteomic profiling of MCF-7 breast cancer cells with chemoresistance to different types of anti-cancer drugs. Int. J. Oncol. 2007, 30, 1545-1551.
39. Wang, Y., Serfass, L., Roy, M. O., Wong, J. et al., Annexin-I expression modulates drug resistance in tumor cells. Biochem. Biophys. Res. Commun. 2004, 314, 565-570.
40. Fukata, Y., Itoh, T. J., Kimura, T., Menager, C. et al., CRMP-2 binds to tubulin heterodimers to promote microtubule assembly. Nat. Cell Biol. 2002, 4, 583-591.
41. Shtutman, M., Chausovsky, A., Prager-Khoutorsky, M., Schiefermeier, N. et al., Signaling function of alpha-catenin in microtubule regulation. Cell Cycle 2008, 7, 2377-2383.
42. Malz, M., Weber, A., Singer, S., Riehmer, V. et al., Overexpression of far upstream element binding proteins: a mechanism regulating proliferation and migration in liver cancer cells. Hepatology 2009, 50, 1130-1139.
43. Kang, B. H., Altieri, D. C., Regulation of survivin stability by the aryl hydrocarbon receptor-interacting protein. J. Biol. Chem. 2006, 281, 24721-24727.
44. Wu, D., Haruta, A., Wei, Q., GIPC1 interacts with MyoGEF and promotes MDA-MB-231 breast cancer cell invasion. J. Biol. Chem. 2010, 285, 28643-28650.
45. Huffman, K. E., Corey, D. R., Major vault protein does not play a role in chemoresistance or drug localization in a non-small cell lung cancer cell line. Biochemistry 2005, 44, 2253-2261.
46. Verdier-Pinard, P., Shahabi, S., Wang, F., Burd, B. et al., Detection of human betaV-tubulin expression in epithelial cancer cell lines by tubulin proteomics. Biochemistry 2005, 44, 15858-15870.
47. Kinoshita, M., Noda, M., Roles of septins in the mammalian cytokinesis machinery. Cell. Struct. Funct. 2001, 26, 667-670.
48. Surka, M. C., Tsang, C. W., Trimble, W. S., The mammalian septin MSF localizes with microtubules and is required for completion of cytokinesis. Mol. Biol. Cell 2002, 13, 3532-3545.
49. Nagata, K., Kawajiri, A., Matsui, S., Takagishi, M. et al., Filament formation of MSF-A, a mammalian septin, in human mammary epithelial cells depends on interactions with microtubules. J. Biol. Chem. 2003, 278, 18538-18543.
50. Spiliotis, E. T., Hunt, S. J., Hu, Q., Kinoshita, M., Nelson, W. J., Epithelial polarity requires septin coupling of vesicle transport to polyglutamylated microtubules. J. Cell Biol. 2008, 180, 295-303.
51. Kremer, B. E., Haystead, T., Macara, I. G., Mammalian septins regulate microtubule stability through interaction with the microtubule-binding protein MAP4. Mol. Biol. Cell 2005, 16, 4648-4659.
52. Hanai, N., Nagata, K., Kawajiri, A., Shiromizu, T. et al., Biochemical and cell biological characterization of a mammalian septin, Sept11. FEBS Lett. 2004, 568, 83-88.
53. Amir, S., Mabjeesh, N. J., SEPT9-V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents. Cancer Biol. Ther. 2007, 6, 1926-1931.
54. Liu, M., Shen, S., Chen, F., Yu, W., Yu, L., Linking the septin expression with carcinogenesis. Mol. Biol. Rep. 2010, 37, 3601-3608.
55. Sakai, K., Kurimoto, M., Tsugu, A., Hubbard, S. L. et al., Expression of Nedd5, a mammalian septin, in human brain tumors. J. Neurooncol. 2002, 57, 169-177.
56. Montagna, C., Lyu, M. S., Hunter, K., Lukes, L. et al., The Septin 9 (MSF) gene is amplified and overexpressed in mouse mammary gland adenocarcinomas and human breast cancer cell lines. Cancer Res. 2003, 63, 2179-2187.
57. Gennerich, A., Vale, R. D., Walking the walk: how kinesin and dynein coordinate their steps. Curr. Opin. Cell Biol. 2009, 21, 59-67.
58. Pratt, W. B., Morishima, Y., Murphy, M., Harrell, M., Chaperoning of glucocorticoid receptors. Handbook Exp. Pharmacol. 2006, 172, 111-138.
59. den Hollander, P., Kumar, R., Dynein light chain 1 contributes to cell cycle progression by increasing cyclin-dependent kinase 2 activity in estrogen-stimulated cells. Cancer Res. 2006, 66, 5941-5949.
60. Lawrence, C. J., Dawe, R. K., Christie, K. R., Cleveland, D. W. et al., A standardized kinesin nomenclature. J. Cell Biol. 2004, 167, 19-22.
61. Hirokawa, N., Noda, Y., Tanaka, Y., Niwa, S., Kinesin superfamily motor proteins and intracellular transport. Nat. Rev. Mol. Cell Biol. 2009, 10, 682-696.
62. Marceiller, J., Drechou, A., Durand, G., Perez, F., Poüs, C., Kinesin is involved in protecting nascent microtubules from disassembly after recovery from nocodazole treatment. Exp. Cell Res. 2005, 304, 483-492.
63. Daire, V., Giustiniani, J., Leroy-Gori, I., Quesnoit, M. et al., Kinesin-1 regulates microtubule dynamics via a c-Jun N-terminal kinase-dependent mechanism. J. Biol. Chem. 2009, 284, 31992-32001.
64. De, S., Cipriano, R., Jackson, M. W., Stark, G. R., Overexpression of kinesins mediates docetaxel resistance in breast cancer cells. Cancer Res. 2009, 69, 8035-8042.
65. Brown, K. J., Fenselau, C., Investigation of doxorubicin resistance in MCF-7 breast cancer cells using shot-gun comparative proteomics with proteolytic 18O labeling. J. Proteome Res. 2004, 3, 455-462.
66. Gehrmann, M. L., Fenselau, C., Hathout, Y., Highly altered protein expression profile in the adriamycin resistant MCF-7 cell line. J. Proteome Res. 2004, 3, 403-409.